Nalaganje...
Impact of renin-angiotensin system inhibitors on mortality during the COVID Pandemic among STEMI patients undergoing mechanical reperfusion: Insight from an international STEMI registry
BACKGROUND: Concerns have been raised on a potential interaction between renin-angiotensin system inhibitors (RASI) and the susceptibility to coronavirus disease 2019 (COVID-19). No data have been so far reported on the prognostic impact of RASI in patients suffering from ST-elevation myocardial inf...
Shranjeno v:
| izdano v: | Biomed Pharmacother |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
The Authors. Published by Elsevier Masson SAS.
2021
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7962982/ https://ncbi.nlm.nih.gov/pubmed/33740523 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.biopha.2021.111469 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|